The Food & Drug Administration earlier this month cleared for marketing a test that simultaneously detects and identifies 12 specific respiratory viruses from a single sample. The xTAG Respiratory Viral Panel is the first test to spot and differentiate influenza A subtypes H1 and H3. Influenza A is the most severe form of the flu for humans and has caused major epidemics. The panel is also the first test for human metapneumovirus (hMPV), newly identified in 2001.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

January 28, 2008 - Table of Contents

NIR January 28, 2008 (full issue PDF)

Labs Ratchet Up Game Plan to Block Lab Bidding Demo

Physician Fee Fix Issues in Flux

Regulating IVDMIAs: A Closer Look at ACLA’s Proposed Model

Legislative Outlook for Medicare Changes in 2008: Key Priorities for Clinical Labs, Pathologists

FDA Okays 1st Test to Identify 12 Respiratory Viruses

Pathology Claims Advisory

CMS to Adjust Payment for New Metabolic Panel Code